reports
Ipsen announces the availability of its 2025 Universal Registration Do...
Ipsen announces the availability of its 2025 Universal Registration Document Ipsen announces the availability of its 2025 Universal Registration Document PARIS, FRANCE, 1 APRIL 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced that its 2025 Universal Registration Document has been filed today with the French Autorité des Marchés Financiers (AMF) and registered under the number D.26-0202. The document is available on and . Copies will also be available at Ipsen’s headquarters – 70 rue Balard, 75015 Paris, France. The Universal Registration Document includes in particular: the Annual F...
Ipsen annonce la mise à disposition de son Document d’enregistrement u...
Ipsen annonce la mise à disposition de son Document d’enregistrement universel 2025 Ipsen annonce la mise à disposition de son Document d’enregistrement universel 2025 PARIS, FRANCE, 1er AVRIL 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce que son Document d’enregistrement universel 2025 a été déposé ce jour auprès de l’Autorité des Marchés Financiers (AMF) et enregistré sous le numéro D.26-0202. Ce document peut être consulté sur le site internet de la société à l’adresse et sur le site de l’AMF . Il sera également tenu à disposition au siège social de la Société – 70 rue Balard, 7...
- Emmanuel Matot
- Roy Külter
- Steven Boumans
NK IMERYS SA
LI KLEPIERRE SA
COV COVIVIO SA
GFC GECINA SA
NXI NEXITY SA CLASS A
GYC GRAND CITY PROPERTIES SA
LEI LEIFHEIT AG
MERY MERCIALYS SA
INEA FONCIERE INEA
WHA WERELDHAVE N.V.
BLND BRITISH LAND COMPANY PLC
VETO VETOQUINOL SA
KOF KAUFMAN & BROAD SA
ALTA ALTAREA SCA
VNA VONOVIA SE
MOBN MOBIMO HOLDING AG
XIOR XIOR STUDENT HOUSING N.V.
ICAD ICADE SA
BYG BIG YELLOW GROUP PLC
UTG UNITE GROUP PLC
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
COFB COFINIMMO SA
CAI CA IMMOBILIEN ANLAGEN AG
TEG TAG IMMOBILIEN AG
VASTB VASTNED RETAIL BELGIUM NV
ALLN ALLREAL HOLDING AG
KOMN KOMAX HOLDING AG
PSPN PSP SWISS PROPERTY AG
UBS UBM DEVELOPMENT AG
SPSN SWISS PRIME SITE AG
PAT PATRIZIA AG
MONT MONTEA SCA
AED AEDIFICA SA
CARM CARMILA SAS
LEG LEG IMMOBILIEN AG
IRES IRISH RESIDENTIAL PROPERTIES REIT PLC
CPINV CARE PROPERTY INVEST SA
SAFE SAFESTORE HOLDINGS PLC
ARG ARGAN SA
VGP VGP NV
COL INMOBILIARIA COLONIAL SOCIMI SA
DIC DIC ASSET AG
MERLIN MERLIN PROPERTIES SOCIMI S.A.
IREN INVESTIS HOLDING SA
SRE SIRIUS REAL ESTATE LIMITED
HOME NEINOR HOMES SA
AT1 AROUNDTOWN SA
LAND LAND SECURITIES GROUP PLC
MVC METROVACESA SA
IGD IMMOBILIARE GRANDE DISTRIBUZIONE SIIQ S.P.A.
NSI NSI N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
INS INSTONE REAL ESTATE GROUP AG
AEDAS AEDAS HOMES SA
WDP WAREHOUSES DE PAUW SCA
ECMPA EUROCOMMERCIAL PROPERTIES NV
ALAFY AFYREN
CTPNV CTP NV
SHUR SHURGARD SELF STORAGE LIMITED
4X0 STEYR MOTORS AG
IS INTERSHOP HOLDING AG
- Jean-François Granjon
- Louis Boujard
- CFA
EVT EVOTEC SE
PHA PHARMAGEST INTERACTIVE SA
ALDEL DELFINGEN INDUSTRY SA
OERL OC OERLIKON CORPORATION AG
VRAP VRANKEN-POMMERY MONOPOLE SA
VETO VETOQUINOL SA
NOEJ NORMA GROUP SE
POS PORR AG
ADN1 ADESSO AG
ALBFR SIDETRADE SA
SMHN SUESS MICROTEC AG
CSM CORBION NV
WPL WIRTUALNA POLSKA HOLDING SA
DMP DERMAPHARM HOLDING SE
ATRY ATRYS HEALTH
S30 SOLUTIONS 30 SE
KTA KNAUS TABBERT
LHYFE LHYFE S.A.
CO CASINO GUICHARD-PERRACHON
- Bruno Cavalier
- Luis de Toledo Heras
- Thomas Zlowodzki
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
UTDI UNITED INTERNET AG
EL ESSILORLUXOTTICA SA
PHA PHARMAGEST INTERACTIVE SA
FAGR FAGRON SA
BRBY BURBERRY GROUP PLC
VETO VETOQUINOL SA
KER KERING SA
BOSS HUGO BOSS AG
NANO NANOBIOTIX SA
01913 PRADA S.P.A.
AIXA AIXTRON SE
MLP MLP SE
PAT PATRIZIA AG
MONC MONCLER SPA
ENG ENAGAS SA
SMHN SUESS MICROTEC AG
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
TCH TECHNICOLOR SA
ZGN ERMENEGILDO ZEGNA NV
DIA DISTRIBUIDORA INTERNACIONAL DE ALIMENTACION SA
- Christophe-Raphaël Ganet
- Jerôme Bodin
APAML APERAM SA
ZIL2 ELRINGKLINGER AG
HCO HIGHCO SA
CGM CEGEDIM SA
PSM PROSIEBENSAT.1 MEDIA SE
VETO VETOQUINOL SA
LNA LNA SANTE SA
CAI CA IMMOBILIEN ANLAGEN AG
CWC CEWE STIFTUNG & CO KGAA
UBS UBM DEVELOPMENT AG
SLIGR SLIGRO FOOD GROUP N.V.
ONTEX ONTEX GROUP N.V.
DGM DIAGNOSTIC MEDICAL SYSTEMS
WPL WIRTUALNA POLSKA HOLDING SA
JUN3 JUNGHEINRICH AG PREF
JST JOST WERKE AG
2CRSI 2CRSI SA
S92 SMA SOLAR TECHNOLOGY AG
MRX MISTER SPEX SE
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
AROBS AROBS TRANSILVANIA SOFTWARE SA
FLOW FLOW TRADERS LTD
IOS IONOS GROUP SE
ARVEN ARVERNE GROUP SA
- Jerôme Bodin
APAML APERAM SA
ZIL2 ELRINGKLINGER AG
HCO HIGHCO SA
CGM CEGEDIM SA
PSM PROSIEBENSAT.1 MEDIA SE
VETO VETOQUINOL SA
LNA LNA SANTE SA
CAI CA IMMOBILIEN ANLAGEN AG
CWC CEWE STIFTUNG & CO KGAA
UBS UBM DEVELOPMENT AG
SLIGR SLIGRO FOOD GROUP N.V.
ONTEX ONTEX GROUP N.V.
DGM DIAGNOSTIC MEDICAL SYSTEMS
WPL WIRTUALNA POLSKA HOLDING SA
JUN3 JUNGHEINRICH AG PREF
JST JOST WERKE AG
2CRSI 2CRSI SA
S92 SMA SOLAR TECHNOLOGY AG
MRX MISTER SPEX SE
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
AROBS AROBS TRANSILVANIA SOFTWARE SA
FLOW FLOW TRADERS LTD
IOS IONOS GROUP SE
ARVEN ARVERNE GROUP SA
- Christophe-Raphaël Ganet
- Christophe-Raphaël Ganet
- Amira Manai
- Andreas Riemann
A1XEH4 CROSSJECT SA
SBS STRATEC SE
LXS LANXESS AG
HCO HIGHCO SA
IPH INNATE PHARMA SA CLASS A
NTG NETGEM SA
NRG NRJ GROUP SA
LNA LNA SANTE SA
TRI TRIGANO SA
QDT QUADIENT SA
POS PORR AG
FFP FFP
DEZ DEUTZ AG
WIE WIENERBERGER AG
AALB AALBERTS N.V.
FACC FACC AG
SANT S&T AG
RBO ROCHE BOBOIS INTERNATIONAL SAS
JEN JENOPTIK AG
CLA CLARANOVA SE
ALHGR HOFFMANN GREEN CEMENT TECHNOLOGIES SA
MRX MISTER SPEX SE
ARVEN ARVERNE GROUP SA
- Amira Manai
- Andreas Riemann
A1XEH4 CROSSJECT SA
SBS STRATEC SE
LXS LANXESS AG
HCO HIGHCO SA
IPH INNATE PHARMA SA CLASS A
NTG NETGEM SA
NRG NRJ GROUP SA
LNA LNA SANTE SA
TRI TRIGANO SA
QDT QUADIENT SA
POS PORR AG
FFP FFP
DEZ DEUTZ AG
WIE WIENERBERGER AG
AALB AALBERTS N.V.
FACC FACC AG
SANT S&T AG
RBO ROCHE BOBOIS INTERNATIONAL SAS
JEN JENOPTIK AG
CLA CLARANOVA SE
ALHGR HOFFMANN GREEN CEMENT TECHNOLOGIES SA
MRX MISTER SPEX SE
ARVEN ARVERNE GROUP SA
- Martial Descoutures
- Oussema Denguir
- Martial Descoutures
- Oussema Denguir
Ipsen showcases transformative potential of early immuno-oncology pipe...
Ipsen showcases transformative potential of early immuno-oncology pipeline at AACR IPN01203 data to be presented at coveted New Drugs on the Horizon program session, demonstrating early potential of this novel T cell activator to transform care in solid tumors ITGA2 revealed as novel target of Ipsen’s investigational antibody drug conjugate IPN60300, over-expressed across numerous solid tumor typesPreclinical data show potential of Ipsen’s growing collection of investigational medicines, leveraging precision immuno‑modulation to deliver differentiated anti‑tumor activity PARIS, FRANCE, 18 ...
Ipsen présente le potentiel transformateur de son pipeline d’immuno on...
Ipsen présente le potentiel transformateur de son pipeline d’immuno oncologie précoce au congrès AACR Les données précliniques d’IPN01203 seront dévoilées lors de la convoitée session « New Drugs on the Horizon », mettant en lumière le potentiel précoce de ce nouvel activateur de cellules T à transformer la prise en charge des tumeurs solides.ITGA2 identifié comme nouvelle cible de l’anticorps-conjugué (ADC) innovant IPN60300 d’Ipsen, fortement surexprimée dans de nombreux types de tumeurs solides.Ces données précliniques illustrent le potentiel croissant du portefeuille de médicaments expé...
Ipsen - February 2026 - Monthly information relative to the total numb...
Ipsen - February 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150LEI: 549300M6SGDPB4Z94P11 DateTotal number of shares composing the share capitalTotal number of voting rights (1)28 February 2026 83,814,526 Gross total* of ...
Ipsen - Février 2026 - Information mensuelle relative au nombre total ...
Ipsen - Février 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Information mensuelle relative au nombre total des droits de voteet d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerceet à l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : Euronext Paris Code ISIN : FR 0010259150LEI : 549300M6SGDPB4Z94P11 Date Nombre total d’actions composant le capital social Nombre total de droits de vote (1) 28 février 2...
Ipsen appoints Michelle C. Werner as EVP, President of North America
Ipsen appoints Michelle C. Werner as EVP, President of North America PARIS, FRANCE, 12 March 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Michelle C. Werner as Executive Vice President (EVP), President of North America, effective 23 March 2026. Michelle will serve on the Executive Leadership Team (ELT) and will report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “I am very pleased to welcome Michelle to Ipsen and to the Executive Leadership Team. She brings a wealth of experience in leading teams both in the U.S. and around the world and has...
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follic...
Update: Ipsen voluntarily withdraws Tazverik® (tazemetostat) in follicular lymphoma and epithelioid sarcoma PARIS, FRANCE, 09 March 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it is voluntarily withdrawing Tazverik® (tazemetostat) in all indications from all Ipsen markets. Ipsen’s decision to withdraw is based on emerging data from the ongoing Phase Ib/III SYMPHONY-1 trial (evaluating tazemetostat in combination with lenalidomide plus rituximab (R2) vs R2 in follicular lymphoma). The Independent Data Monitoring Committee (IDMC) advised that, based on adverse events of seco...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.